Albany, NY -- (SBWIRE) -- 11/26/2014 -- According to a new market report published by Transparency Market Research “Cervical Cancer Diagnostic Tests Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” the global cervical cancer diagnostic tests market was valued at USD 11.9 billion in 2013 and is expected to grow at a CAGR of 6.2% from 2014 to 2020, to reach an estimated value of USD 18.1 billion in 2020.

Cervical cancer develops in cervix due to abnormal growth of cervical cells, and is commonly spread through a virus termed as human papillomavirus (HPV). Presently, the cervical cancer diagnostic tests market is growing at a rapid pace due to increasing prevalence and deaths caused due to cervical cancer across the globe. According to the World Health Organization (WHO), cervical cancer accounts for deaths of more than 270,000 women each year, primarily in the developing countries. With the increasing use of cervical cancer diagnostic tests such as Pap smear tests, HPV testing and colposcopy for early detection, the market is described as highly competitive with high growth rate.

Browse Full Cervical Cancer Diagnostic Tests Market Report : http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

Increasing incidences of weakened immune system, rapid spread of human papillomavirus (HPV) infection among the female population and long-term use of oral contraceptive pills are the primary factors responsible for the growth of cervical cancer diagnostic tests market. Furthermore, other lifestyle-related factors such as smoking, having multiple sex partners and certain family history of cervical cancer are anticipated to drive the growth of the market in the near future. The advent of technologically advanced computer-guided screening tests for cervical cancer to reduce the rate of false-negative test results and improve accuracy would contribute to the growth of the cervical cancer diagnostic tests market during the forecast period from 2014 to 2020. However, certain restraining factors such as lack of education regarding the prevalence of cervical cancer and reluctance of the female population to undergo cervical cancer prognosis would hinder the growth of the market. Moreover, unfavorable taxation and lack of favorable reimbursement policies in the European and Asian countries have affected the growth of the market negatively.

Browse Press Release : http://www.transparencymarketresearch.com/pressrelease/cervical-cancer-diagnostic-tests-market.htm

The HPV testing segment accounted for the largest share of over 45% of the total cervical cancer diagnostic tests market in 2013. Factors attributed to the dominance of the HPV testing segment are high prevalence rate of HPV-infected individuals and growing awareness about cancer diagnosis and early detection. Additionally, increasing preference of the population for the most advanced therapeutic treatment is accelerating the growth of the segment. Similarly, in terms of growth rate, the Pap smear tests segment is forecasted to grow at the fastest growth rate of more than 6% from 2014 to 2020 of the cervical cancer diagnostic tests market. Rapid growth of the Pap smear tests segment has been attributed to the increasing use of Pap smear test to diagnose cervical cancer, high prevalence rate of cervical cancer and favorable reimbursement scenario in developed countries.

Geographically, North America accounted for the largest share of the total cervical cancer diagnostic tests market in 2013. However, Asia Pacific countries such as Japan, South Korea, Malaysia, Australia, Thailand, India and China are witnessing remarkable growth and are anticipated to emerge as promising markets in the near future due to increasing awareness about the diagnosis of cervical cancer, easy market penetration, and increasing disposable income in these developing nations. Moreover, favorable support from governments for healthcare infrastructure would boost the growth of the cervical cancer diagnostic tests market in Asia Pacific.

High growth rate of the cervical cancer diagnostic tests market is likely to attract various top players. Major players operating in the cervical cancer diagnostic tests market are Abbott Laboratories, Becton, Dickinson and Company, Femasys, Inc., Hologic, Inc., Guided Therapeutics, Inc., OncoHealth Corp., Quest Diagnostics, Inc., Roche Diagnostics, QIAGEN, and Zilico Ltd.

Browse the full Cervical Cancer Diagnostic Tests Market (Pap Smear tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Others (Cone Biopsy and Loop Electrosurgical Excision Procedure (LEEP) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=736

The global cervical cancer diagnostic tests market is segmented as follows:
- Cervical Cancer Diagnostic Tests Market, by Type of Tests
- Pap Smear Tests
- Colposcopy
- HPV Testing
- Endocervical Curettage (ECC)
- Others {Cone Biopsy and Loop Electrosurgical Excision Procedure (LEEP)}

Cervical Cancer Diagnostic Tests Market, by Geography:
- North America
- Europe
- Asia Pacific
- Rest of the World (RoW)

About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.